GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Celltrion 068270.KS · KRW

Health Care · Biotechnology · KRX · 🇰🇷 South Korea

Compare

210,000

-0.47%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Celltrion — daily KRX:068270

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Celltrion on TradingView ↗
Market value
₩48.16trn
Last close × shares
Volume
645.1k
Shares, 9 Nov 2026
Price to earnings
40.9
Dividend yield
0.36%

About Celltrion

Its shares trade on KRX under the ticker 068270.KS. It has been listed since 19 July 2005. In the fiscal year to 31 December 2025, it reported revenue of ₩4.16trn and net income of ₩1.03trn. At that date it held total assets of ₩22.33trn and shareholders' equity of ₩17.21trn.

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. The company is headquartered in Incheon, Incheon. The company went IPO on 2005-07-19. The firm operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The firm's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The firm sells its products in domestic and overseas markets such as Europe and the United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Celltrion →

Latest on Celltrion

Our reporting

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of 2036.87 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Celltrion's ticker?

Celltrion trades as 068270.KS on KRX, under ISIN KR7068270008.

What was Celltrion's last closing price?

210,000 on 9 Nov 2026. The figure is in KRW and is never converted.

When does Celltrion next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.